Christine Fox
EVP, U.S. Commercial · 3 filings · Latest: Apr 30, 2026
TEVA PHARMACEUTICAL INDUSTRIES LTD
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TEVA | Christine Fox | EVP, U.S. Commercial | Apr 30, 2026 | Sale | $35.31 | 21,258 | $750.6K | 63,647 | |
TEVA | Christine Fox | — | Apr 30, 2026 | Proposed Sale | $35.31 | 21,258 | $750.6K | — | |
TEVA | Christine Fox | EVP, U.S. Commercial | Mar 5, 2026 | Sale | $31.67 | 7,924 | $250.9K | 84,905 | |
TEVA | Christine Fox | EVP, U.S. Commercial | Mar 5, 2026 | Option Exercise | — | 17,819 | — | 92,829 | |
TEVA | Christine Fox | EVP, U.S. Commercial | Mar 4, 2026 | Sale | $32.46 | 9,098 | $295.4K | 75,010 | |
TEVA | Christine Fox | EVP, U.S. Commercial | Mar 4, 2026 | Option Exercise | — | 20,461 | — | 84,108 | |
TEVA | Fox Christine | — | Mar 5, 2026 | Proposed Sale | $31.67 | 7,924 | $250.9K | — | |
TEVA | Fox Christine | — | Mar 4, 2026 | Proposed Sale | $32.46 | 9,908 | $321.7K | — | |
TEVA | Fox Christine | — | Nov 20, 2025 | Proposed Sale | $24.78 | 28,229 | $699.5K | — | |
TEVA | Fox Christine | — | Nov 14, 2025 | Proposed Sale | $25.11 | 30,000 | $753.3K | — | |
TEVA | Fox Christine | — | Mar 4, 2025 | Proposed Sale | $16.00 | 6,181 | $98.9K | — | |
TEVA | Fox Christine | — | Nov 20, 2024 | Proposed Sale | $16.87 | 19,388 | $327.1K | — |